Dr. Joydeep Chakrabartty

Dr. Joydeep is an experienced haemato oncologist with over 20 years of experience in the diagnosis, treatment, and overall management of haematological disorders, such as leukaemia, myeloma, and other blood disorders. Dr. Joydeep’s primary interest lies in the areas of bone marrow transplantation (BMT), especially mismatched high-end transplants for all conditions, especially acute leukaemias. He is very competent in the laboratory diagnostic part of haematological diseases. He is exceptionally skilled in critical care medicine too.

• 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer Dominique Farge*, Corinne Frere*, Jean M Connors, Cihan Ay, Alok A Khorana, Andres Munoz, Benjamin Brenner, Ajay Kakkar, Hanadi Rafii, Susan Solymoss, Dialina Brilhante, Manuel Monreal, Henri Bounameaux, Ingrid Pabinger, James Douketis, Joydeep Chakrabartty as a part of the International Initiative on Thrombosis and Cancer (ITAC) advisory panel; Lancet Oncol 2019; Published Online, September 3, 2019 http: //dx.doi.org/10.1016/S1470-2045(19)30336-5
• Economic benefits of centrifugal method in therapeutic plasma exchange: experience from private hospitals in India- accepted for oral presentation- International Society of Apheresis, Kyoto , Japan, Oct 2019.
• Treosulfan based allogenic conditioning regimes including the use of Generic Treosulfan in Haematological malignancies – poster number 277, BMT Tandem meetings, 2019,
• Dikshit N, Sinha R, Maity H, et al. Dose escalation study of bendamustine based conditioning regime (Bace-bendamustine, cytarabine, cyclophosphamide and etoposide) in patients with lymphoma undergoing autologous stem cell transplant. Hematol Transfus Int J. 2017;5(5):294‒297.
• BMT TANDEM MEETING 2017(ASBMT) Bendamustine Based Conditioning Regime (BACE-Bendamustine, Cytarabine, Cyclophosphamide and Etoposide) for Patients with Lymphoma Undergoing Autologous Stem Cell Transplant Jain, Neelesh, Amrita Chakrabarti, Rajani Sinha , Nitin Sood, Anil Arabandi, Kasturi Sengupta and Joydeep Chakrabartty
• BMT TANDEM MEETING 2017(ASBMT) Safety and efficacy of Darbapoietin alpha in minimizing transfusion requirements in autologous stem cell transplantation.
• Neelesh Jain, Amrita Chakrabarti, Rajani Sinha , Nitin Sood, Anil Arabandi, Kasturi Sengupta and Joydeep Chakrabartty     Amrita Chakrabarti, Priyanka Samal, Joydeep Chakrabartty, Journal of Clinical and Diagnostic research, 2016 Sep, Vol-10(9), ED04-ED05.
• Bilateral combined Retinal Vascular Occlusion: An ocular presentation in Central Nervous system Re-relapse of Non Hodgkins Lymphoma, Amrita Chakrabarti, Priyanka Samal, Joydeep Chakrabartty, Opthalmology Research, 5(4), 1-5, 2016, article number-OR26848.
• A rare case of myelofibrosis secondary to juvenile idiopathic arthritis. Jain, N., Sinha, R., Sengupta, J. and Chakrabartty, J. British Journal of Haematology. doi: 10.1111/bjh.14106     Total Marrow Irradiation (TMI) Based T- Replete Myeloablative Haploidentical Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in Second Complete Remission: A Single Center Experience of Two Cases Jain, Neelesh, Amitabha Roy and Joydeep Chakrabartty; Biology of Blood and Marrow Transplant , Volume 22 , Issue 3 , S308
• Bendamustine Based Conditioning Regime (BACE-Bendamustine, Cytarabine, Cyclophosphamide and Etoposide) for Patients with Lymphoma Undergoin